Passive Immunization Against Tumour Necrosis Factor-alpha (TNF-alpha) and IL-1 Beta Protects from LPS Enhancing Glomerular Injury in Nephrotoxic Nephritis in Rats

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1992 Nov 1

PMID 1385027

Citations 18

Authors

A M Karkar

Y Koshino

S J Cashman

A C Dash

J Bonnefoy

A Meager

A J Rees

Affiliations

Soon will be listed here.

Abstract

Glomerular injury caused by injection of heterologous anti-glomerular basement membrane antibodies (anti-GBM Ab) is increased in rats pretreated with small doses of bacterial lipopolysaccharide (LPS). We have investigated the involvement of tumour necrosis factor-alpha (TNF-alpha), IL-1 alpha and IL-1 beta in this phenomenon by passive immunization against these cytokines. Anti-TNF-alpha or anti-IL-1 beta antibodies given 1.5 h before the induction of nephritis significantly decreased injury in this model, whether assessed by the magnitude of albuminuria, the prevalence of glomerular capillary thrombi or the intensity of glomerular neutrophil infiltrate. Albuminuria in anti-GBM Ab alone was 11 +/- 3, LPS/anti-GBM Ab 87 +/- 22, and anti-TNF-alpha antibodies/LPS/anti-GBM Ab 21 +/- 6 mg/24 h (mean +/- s.e.) P < 0.05. Passive immunization with antibodies to IL-1 beta had a similar effect (anti-GBM Ab, 0.6 +/- 0.1, LPS/anti-GBM Ab, 92 +/- 19, anti-IL-1 beta antibodies/LPS/anti-GBM Ab 39 +/- 8 mg/24 h, P < 0.05). The prevalence of glomerular capillary thrombi was also reduced significantly by these treatments; from 22 +/- 5% to 4 +/- 1% in the case of anti-TNF-alpha antibodies and 28 +/- 5% to 13 +/- 4% with anti-IL-1 beta antibodies. Similarly, the glomerular neutrophil infiltrate was also reduced by these treatments; from 42 +/- 3 to 25 +/- 1 in the case of anti-TNF-alpha and 47 +/- 2 to 30 +/- 1 with anti-IL-1 beta antibodies. In contrast, passive immunization against IL-1 alpha had no effect on either albumin excretion (4 +/- 3, 83 +/- 22 and 77 +/- 24 mg/24 h), glomerular capillary thrombi (2 +/- 1; 19 +/- 5 and 16 +/- 3) or glomerular neutrophil infiltrate (22 +/- 3; 47 +/- 5 and 48 +/- 5 from the three groups respectively). These results demonstrate that enhanced antibody mediated injury in the kidney is modulated by TNF-alpha and IL-1 beta but not by IL-1 alpha.

Citing Articles

Live Imaging of Monocyte Subsets in Immune Complex-Mediated Glomerulonephritis Reveals Distinct Phenotypes and Effector Functions.

Turner-Stokes T, Diaz A, Pinheiro D, Prendecki M, McAdoo S, Roufosse C J Am Soc Nephrol. 2020; 31(11):2523-2542.

PMID: 32868399 PMC: 7608972. DOI: 10.1681/ASN.2019121326.

The NF-κB1 is a key regulator of acute but not chronic renal injury.

Fearn A, Situmorang G, Fox C, Oakley F, Howarth R, Wilson C Cell Death Dis. 2017; 8(6):e2883.

PMID: 28617440 PMC: 5584573. DOI: 10.1038/cddis.2017.233.

Is the inflammasome a potential therapeutic target in renal disease?.

Turner C, Arulkumaran N, Singer M, Unwin R, Tam F BMC Nephrol. 2014; 15:21.

PMID: 24450291 PMC: 3918225. DOI: 10.1186/1471-2369-15-21.

Tumor necrosis factor-α: regulation of renal function and blood pressure.

Ramseyer V, Garvin J Am J Physiol Renal Physiol. 2013; 304(10):F1231-42.

PMID: 23515717 PMC: 3651627. DOI: 10.1152/ajprenal.00557.2012.

Anti-GBM glomerulonephritis involves IL-1 but is independent of NLRP3/ASC inflammasome-mediated activation of caspase-1.

Lichtnekert J, Kulkarni O, Mulay S, Rupanagudi K, Ryu M, Allam R PLoS One. 2011; 6(10):e26778.

PMID: 22046355 PMC: 3203143. DOI: 10.1371/journal.pone.0026778.

References

Pinching A, Rees A, Pussell B, Lockwood C, Mitchison R, PETERS D . Relapses in Wegener's granulomatosis: the role of infection. Br Med J. 1980; 281(6244):836-8. PMC: 1714254. DOI: 10.1136/bmj.281.6244.836. View

El Nahas A, Lechler R, Zoob S, Rees A . Progression to renal failure after nephrotoxic nephritis in rats studied by renal transplantation. Clin Sci (Lond). 1985; 68(1):15-21. DOI: 10.1042/cs0680015. View

Vargas R, Thomson K, Wilson D, Cameron J, Turner D, Gill D . Mesangiocapillary glomerulonephritis with dense "deposits" in the basement membranes of the kidney. Clin Nephrol. 1976; 5(2):73-82. View

Ward P, Fuller R, Ritter J, Cashman S, Rees A, Dollery C . Excretion of metabolites of prostacyclin and thromboxane by rats with nephrotoxic nephritis: effects of interleukin-1. Br J Pharmacol. 1991; 103(3):1663-8. PMC: 1907815. DOI: 10.1111/j.1476-5381.1991.tb09844.x. View

Boraschi D, Villa L, Volpini G, Bossu P, Censini S, Ghiara P . Differential activity of interleukin 1 alpha and interleukin 1 beta in the stimulation of the immune response in vivo. Eur J Immunol. 1990; 20(2):317-21. DOI: 10.1002/eji.1830200213. View

Bergh A, Soder O . Interleukin-1 beta but not interleukin-1 alpha, induces acute inflammation-like changes in the testicular microcirculation of adult rats. J Reprod Immunol. 1990; 17(2):155-65. DOI: 10.1016/0165-0378(90)90033-3. View

Mahadevan V, Malik S, Meager A, Fiers W, Lewis G, Hart I . Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown. Cancer Res. 1990; 50(17):5537-42. View

Baumann H, Onorato V, Gauldie J, Jahreis G . Distinct sets of acute phase plasma proteins are stimulated by separate human hepatocyte-stimulating factors and monokines in rat hepatoma cells. J Biol Chem. 1987; 262(20):9756-68. View

COTRAN R, Pober J . Effects of cytokines on vascular endothelium: their role in vascular and immune injury. Kidney Int. 1989; 35(4):969-75. DOI: 10.1038/ki.1989.80. View

10.

Tomosugi N, Cashman S, Hay H, Pusey C, Evans D, Shaw A . Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1. J Immunol. 1989; 142(9):3083-90. View

11.

De Young L, Spires D, Kheifets J, Terrell T . Biology and pharmacology of recombinant human interleukin-1 beta-induced rat ear inflammation. Agents Actions. 1987; 21(3-4):325-7. DOI: 10.1007/BF01966505. View

12.

Uehara A, Gottschall P, Dahl R, Arimura A . Stimulation of ACTH release by human interleukin-1 beta, but not by interleukin-1 alpha, in conscious, freely-moving rats. Biochem Biophys Res Commun. 1987; 146(3):1286-90. DOI: 10.1016/0006-291x(87)90788-1. View

13.

Beasley D, Dinarello C, Cannon J . Interleukin-1 induces natriuresis in conscious rats: role of renal prostaglandins. Kidney Int. 1988; 33(6):1059-65. DOI: 10.1038/ki.1988.111. View

14.

Wankowicz Z, Megyeri P, Issekutz A . Synergy between tumour necrosis factor alpha and interleukin-1 in the induction of polymorphonuclear leukocyte migration during inflammation. J Leukoc Biol. 1988; 43(4):349-56. DOI: 10.1002/jlb.43.4.349. View

15.

Ulich T, Del Castillo J, Keys M, GRANGER G, Ni R . Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes. J Immunol. 1987; 139(10):3406-15. View

16.

Beutler B, Milsark I, Cerami A . Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 1985; 229(4716):869-71. DOI: 10.1126/science.3895437. View

17.

Heim W . Relation between rat slow alpha-2-globulin and alpha-2-macroglobulin of other mammals. Nature. 1968; 217(5133):1057-9. DOI: 10.1038/2171057a0. View

18.

Kopaniak M, Issekutz A, Movat H . Kinetics of acute inflammation induced by E coli in rabbits. Quantitation of blood flow, enhanced vascular permeability, hemorrhage, and leukocyte accumulation. Am J Pathol. 1980; 98(2):485-98. PMC: 1903407. View

19.

Gauthier F, MOURAY H . Rat alpha2 acute-phase macroglobulin. Isolation and physicochemical properties. Biochem J. 1976; 159(3):661-5. PMC: 1164166. DOI: 10.1042/bj1590661. View

20.

Rees A, Lockwood C, PETERS D . Enhanced allergic tissue injury in Goodpasture's syndrome by intercurrent bacterial infection. Br Med J. 1977; 2(6089):723-6. PMC: 1632103. DOI: 10.1136/bmj.2.6089.723. View